![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Neose Strikes Deal With German Company
Neose Strikes Deal With German Company
Neose Technologies entered into a research, license and option agreement Thursday with BioGenerix AG of Germany that could earn Neose up to $61.5 million in research milestone payments. BioGenerix is planning to use Neose's proprietary glycopegylation technology to develop a long-acting, next-generation version of an undisclosed, currently marketed therapeutic protein. Neose of Horsham, Pa., and BioGenerix had previously announced a supply and option agreement for the protein.
Philadelphia Business Journal (http://www.bizjournals.com/philadelphia/stories/2005/04/25/daily46.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct